| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
“Advancing bladder preservation: Biomarkers, decision-making, and therapy”
|
McConkey, David
|
|
|
39 |
4 |
p. 199-200
|
artikel
|
| 2 |
A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer
|
Piao, Xuan-Mei
|
|
|
39 |
4 |
p. 237.e21-237.e29
|
artikel
|
| 3 |
Bladder preservation: Translating discovery for clinical impact in urothelial cancer
|
Miyamoto, David T.
|
|
|
39 |
4 |
p. 201-208
|
artikel
|
| 4 |
Can anesthetics affect bladder cancer recurrence? Total intravenous versus volatile anesthesia in patients undergoing robot-assisted radical cystectomy: A single institution retrospective analysis
|
Pfail, John L.
|
|
|
39 |
4 |
p. 233.e1-233.e8
|
artikel
|
| 5 |
Can we perform frozen section instead of repeat transurethral resection in bladder cancer?
|
Değer, Müslim Doğan
|
|
|
39 |
4 |
p. 237.e15-237.e20
|
artikel
|
| 6 |
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study
|
Pecoraro, Angela
|
|
|
39 |
4 |
p. 239.e1-239.e7
|
artikel
|
| 7 |
Contemporary trends in management of stage 1 seminoma
|
Frankel, Jason K
|
|
|
39 |
4 |
p. 240.e1-240.e8
|
artikel
|
| 8 |
Correlates of refusal of radical cystectomy in patients with muscle-invasive bladder cancer
|
Elshabrawy, Ahmed
|
|
|
39 |
4 |
p. 236.e9-236.e20
|
artikel
|
| 9 |
Cover 2 Masthead
|
|
|
|
39 |
4 |
p. IFC
|
artikel
|
| 10 |
C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab
|
Roussel, Eduard
|
|
|
39 |
4 |
p. 239.e17-239.e25
|
artikel
|
| 11 |
Disparities in precision medicine—Examining germline genetic counseling and testing patterns among men with prostate cancer
|
Borno, Hala T.
|
|
|
39 |
4 |
p. 233.e9-233.e14
|
artikel
|
| 12 |
Do patients with a PI-RADS 5 lesion identified on magnetic resonance imaging require systematic biopsy in addition to targeted biopsy?
|
Drobish, Justin N.
|
|
|
39 |
4 |
p. 235.e1-235.e4
|
artikel
|
| 13 |
Editorial Board
|
|
|
|
39 |
4 |
p. i
|
artikel
|
| 14 |
Factors associated with higher prostate biopsy yield: when is software-assisted fusion MRI-targeting necessary?
|
Henning, Grant M
|
|
|
39 |
4 |
p. 234.e15-234.e19
|
artikel
|
| 15 |
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab
|
Marandino, Laura
|
|
|
39 |
4 |
p. 235.e15-235.e21
|
artikel
|
| 16 |
Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder
|
Schuettfort, Victor M.
|
|
|
39 |
4 |
p. 235.e5-235.e14
|
artikel
|
| 17 |
Integrin expression in correlation to clinicopathological features and prognosis of prostate cancer: A systematic review and meta-analysis
|
Drivalos, Alexandros
|
|
|
39 |
4 |
p. 221-232
|
artikel
|
| 18 |
Novel treatment of upper tract urothelial carcinoma in situ with docetaxel in BCG refractory patients
|
Katims, Andrew B.
|
|
|
39 |
4 |
p. 234.e9-234.e13
|
artikel
|
| 19 |
Oncological outcomes of pathologically organ-confined, lymph node-positive prostate cancer after radical prostatectomy
|
Stolzenbach, Lara Franziska
|
|
|
39 |
4 |
p. 234.e1-234.e7
|
artikel
|
| 20 |
Partial nephrectomy should be classified as an inpatient procedure: Results from a statewide quality improvement collaborative
|
Johnson, Kyle
|
|
|
39 |
4 |
p. 239.e9-239.e16
|
artikel
|
| 21 |
Polymorphism in autophagy gene ATG2B is not associated with bladder cancer recurrence after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy in Asian patients
|
Zang, Zhijiang
|
|
|
39 |
4 |
p. 238.e1-238.e7
|
artikel
|
| 22 |
Post-traumatic stress disorder symptoms in non-muscle-invasive bladder cancer survivors: A population-based study
|
Jung, Ahrang
|
|
|
39 |
4 |
p. 237.e7-237.e14
|
artikel
|
| 23 |
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer
|
Horiguchi, Hirotaka
|
|
|
39 |
4 |
p. 238.e9-238.e17
|
artikel
|
| 24 |
Safety evaluation of enzalutamide dose-escalation strategy in patients with castration-resistant prostate cancer
|
Miura, Rieko
|
|
|
39 |
4 |
p. 233.e15-233.e20
|
artikel
|
| 25 |
Setting the stage for bladder preservation
|
Black, Peter C.
|
|
|
39 |
4 |
p. 209-212
|
artikel
|
| 26 |
Systemic therapy and COVID19: Immunotherapy and chemotherapy
|
Gulati, Shuchi
|
|
|
39 |
4 |
p. 213-220
|
artikel
|
| 27 |
Table of Contents
|
|
|
|
39 |
4 |
p. ii-iv
|
artikel
|
| 28 |
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis
|
Rosiello, Giuseppe
|
|
|
39 |
4 |
p. 236.e1-236.e7
|
artikel
|
| 29 |
Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost drivers
|
Kukreja, Janet Baack
|
|
|
39 |
4 |
p. 237.e1-237.e5
|
artikel
|
Tijdschrift beschrijving